New Study for People Carrying the APOL1 AMKD Gene
At ANC, we’re always looking for ways to improve care and bring cutting-edge research to our patients. We recently sat down with Dr. Doyle to talk about an exciting opportunity: the Horizon clinical trial by Maze Therapeutics, a national study focused on addressing genetic kidney disease in Black Americans. What Is the Horizon Trial […]
